Access cutting-edge glioblastoma treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access glioblastoma specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glioblastoma treatment provided free
The trial aims to collect safety, efficacy, exposure, dose- response, pharmacokinetic and pharmacodynamic information of the combination of L19TNF and lomustine at different dose levels in patients with Glioblastoma at progression or recurrence
Sponsor: Philogen S.p.A.
Check if you qualify for this glioblastoma clinical trial in Philadelphia, PA
If you're searching for glioblastoma treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glioblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.